Clinical Trials Logo

Filter by:
NCT ID: NCT00273039 Completed - Anxiety Disorders Clinical Trials

A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder

Start date: August 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the safety and efficacy of GW679769 and paroxetine in subjects with Social Anxiety Disorder

NCT ID: NCT00272779 Completed - HIV Infections Clinical Trials

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and antiviral effects of atazanavir (ATV) plus ritonavir (RTV) versus a combination drug of lopinavir (LPV) plus RTV. A combination drug containing tenofovir (TDF) and emtricitabine (FTC) will also be taken by participants in both arms.

NCT ID: NCT00264667 Completed - Clinical trials for Metabolic Syndrome X

Study In Patients With Dyslipidaemia

Start date: December 2005
Phase: Phase 2
Study type: Interventional

Study in patients with dyslipidaemia.

NCT ID: NCT00259870 Completed - Schizophrenia Clinical Trials

SB-773812 Administered In Adults With Schizophrenia

Start date: September 2005
Phase: Phase 2
Study type: Interventional

This is a two part study designed to evaluate the safety and efficacy of SB-773812 in the treatment of acute schizophrenia. Subjects with acute schizophrenia will be randomized in an adaptive design study to receive placebo, SB-773812 60mg or olanzapine 15mg for 12 weeks in Part A. An interim analysis will be conducted to assess the efficacy and safety of the SB-773812 60mg dose compared with placebo. Based on these data, up to two further doses of SB-773812 will be added to the randomization for Part B.

NCT ID: NCT00258557 Completed - HIV Clinical Trials

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Start date: September 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy, safety and tolerability of TMC114/r versus Kaletra (a combination pill of lopinavir and ritonavir, ("lpv/rtv") in HIV-1 infected patients who have never been treated with anti-retroviral medications (referred to as "treatment-naïve" patients).

NCT ID: NCT00256698 Completed - Breast Cancer Clinical Trials

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

FACT
Start date: January 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the efficacy of anastrozole monotherapy versus maximal oestrogen blockade with combinated therapy of fulvestrant and anastrozole compared with in treatment of hormone receptor positive women with first relapse of breast cancer.

NCT ID: NCT00254046 Completed - HIV Clinical Trials

TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

Start date: November 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is research with the goal of evaluating the effect of TMC125 (a non-nucleoside reverse transcriptase inhibitor) on slowing down the growth of the HIV virus. The study will also investigate whether this new medication is well tolerated, and to further confirm that the medication is safe to be used.

NCT ID: NCT00219622 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary Disease

Start date: May 2004
Phase: Phase 2
Study type: Interventional

This an initial proof of concept, phase to study to assess the safety and efficacy of tofimilast for the chronic maintenance treatment of adults with Chronic Obstructive Pulmonary Disease

NCT ID: NCT00214630 Completed - Clinical trials for Acute Coronary Syndromes

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

Start date: December 2003
Phase: Phase 3
Study type: Interventional

Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes

NCT ID: NCT00210639 Completed - Clinical trials for Musculoskeletal Diseases

A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection

Start date: August 2002
Phase: Phase 3
Study type: Observational

The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.